MEDVi vs Zealthy: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Zealthy scores higher on our rubric, 7.2/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - $179 first month, then $299/mo →or find your match

Zealthy beats MEDVi overall, scoring 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Zealthy is from $286/mo. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose Zealthy for insured users who want dedicated coordinators handling prior authorizations for brand-name glp-1s (potentially $25/mo).

A side-by-side look at MEDVi and Zealthy to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Higher Rated

Zealthy

#36 of 54

7.2/10

Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.

Visit Zealthy

Feature	MEDVi	Zealthy
Why each one	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.	Dedicated insurance coordinators handle prior authorizations for brand-name GLP-1s, plus multi-month supply options up to 12 months.
Our Score	5.7/10	7.2/10
Headline Price	$179 first month, then $299/mo	from $286/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want both oral and injectable compounded options in one telehealth program	Insured users who want dedicated coordinators handling prior authorizations for brand-name GLP-1s (potentially $25/mo)
Watch out for	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication	The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first.
Ranking	#46	#36
Get started	Visit MEDVi	Visit Zealthy

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Zealthy

Pros

+Dedicated insurance coordinators handle prior authorizations, potentially bringing brand-name GLP-1 costs to $25/mo
+Multi-month supply options (3, 6, or 12 months), unique convenience most monthly-shipping competitors can't match
+Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
+LegitScript certified with 4.5-star Review.io rating

Cons

−The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first.
−Young company (founded 2023) with a relatively small review base and less track record than established platforms. Confirm the coordination promise against your own insurance plan before enrolling.
−Prescription products are non-refundable once ordered, for any reason. Double-check dose and supply length before checkout.

Our Verdict

Zealthy edges out MEDVi with a score of 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Zealthy is from $286/mo.